Lexeo Therapeutics, Inc. (LXEO) Income from Continuing Operations (2022 - 2023)
Lexeo Therapeutics' Income from Continuing Operations history spans 2 years, with the latest figure at 14187000.0 for Q4 2023.
- For Q4 2023, Income from Continuing Operations changed N/A year-over-year to 14187000.0; the TTM value through Dec 2023 reached 66394000.0, changed N/A, while the annual FY2024 figure was 98333000.0, 48.11% down from the prior year.
- Income from Continuing Operations for Q4 2023 was 14187000.0 at Lexeo Therapeutics, up from 20109000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 13441000.0 in Q2 2023 and bottomed at 20109000.0 in Q3 2023.